incretin receptor comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-12-11. Numbers and descriptions here follow the published literature rather than marketing material.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
Identity and purity assessment of tirzepatide relies primarily on reversed-phase high-performance liquid chromatography coupled with ultraviolet detection. Mass spectrometry, often in electrospray ionization mode, confirms the molecular mass and detects sequence-related impurities. Peptide mapping after enzymatic digestion provides residue-level confirmation of the backbone. Each method addresses a different question: chromatography for purity and related substances, mass measurement for identity, and mapping for sequence fidelity. No single technique covers all three.
Research and analytical settings increasingly require documentation of peptide origin and chain of custody. Certificate of analysis documents typically report purity by chromatographic area, mass confirmation, appearance, and residual solvent or counterion content. Independent verification by an accredited laboratory is common when a material will be used in a regulated study. Open questions remain about how well compendial methods transfer between laboratories, and about which impurity thresholds are meaningful for materials not intended for clinical use.
Peptide-based pharmaceutical products such as tirzepatide require controlled temperature management to preserve structural integrity. Manufacturer labeling generally specifies refrigeration at 2 to 8 degrees Celsius before first use, with protection from light and freezing. Exposure to repeated temperature cycling can promote aggregation or deamidation, which alters the analytical profile even when the visible solution appears unchanged. Once a product is in use, the permitted storage window and temperature range are defined by the specific labeled presentation rather than by general peptide rules.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Approximate composition of the free peptide |
| Molecular weight | Approximately 4813 Da | Calculated for the free base |
| Structural class | Synthetic linear peptide | 39 residues with modified backbone |
| Solubility | Soluble in water and polar solvents | Behavior of the lyophilized solid |
| Typical storage temperature | -20 degrees Celsius or below | Solid form, protected from light |
Published work supports the view that engaging two incretin receptors produces changes in glucose handling and body weight larger than those seen with single-receptor activation. Why that difference arises is not fully settled. Open questions include how much of the observed weight effect depends on central versus peripheral signaling, and whether the two receptors form interacting complexes. Most reported findings come from controlled trials and animal models, and translation between species is imperfect. Further research is expected to refine these points over time.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.
溶解操作一般使用注射用水或适宜的水性缓冲液，必要时加入少量助溶剂以改善溶解速度，但应避免剧烈涡旋振荡，因为剪切力可能促进聚集。配制后的溶液在冷藏条件下的稳定时间通常短于固体形态，具体时限取决于浓度、缓冲体系与容器材质。是否加入防腐成分，则取决于用途是否为多次取样。
定量分析的主流方法是反相高效液相色谱联用紫外或质谱检测，利用肽在疏水固定相上的保留行为确定纯度与含量。对于生物基质中的浓度测定，常采用液相色谱串联质谱，并配合固相萃取或蛋白沉淀进行样品前处理。免疫分析法也可使用，但可能受到结构相关肽的交叉反应干扰。
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
=== Combinations === Analgesics are frequently used in combination, such as the paracetamol and codeine preparations found in many non-prescription pain relievers. They can also be found in combination with vasoconstrictor drugs such as pseudoephedrine for sinus-related preparations, or with antihistamine drugs for people with allergies. While the use of paracetamol, aspirin, ibuprofen, naproxen, and other NSAIDs concurrently with weak to mid-range opioids (up to about the hydrocodone level) has been said to show beneficial synergistic effects by combating pain at multiple sites of action, several combination analgesic products have been shown to have few efficacy benefits when compared to similar doses of their individual components. Moreover, these combination analgesics can often result in significant adverse events, including accidental overdoses, most often due to confusion that arises from the multiple (and often non-acting) components of these combinations.
30 October – Researchers demonstrate using trained rats as cost-effective detection tools for illegal wildlife trade. Promising results of health and medical research are reported: phase 2-trialed at-home transcranial direct current stimulation against major depressive disorder (21 Oct.), an analysis of electronic health records of 116 million US patients links semaglutide to a significantly reduced risk for Alzheimer's disease (24 Oct.). Hazard research is published: a study finds that the growth rate of wildfires across the western U.S. more than doubled between 2001 and 2020 and that 'fast fires' accounted for ~78% of structures destroyed in the contiguous U.S. (24 Oct.), and a study finds sugar rationing during the first 1000 days after conception reduced type 2 diabetes and hypertension risk by about 35% and 20% (31 Oct.).
==== Metal Recycling and e-waste ==== Occupational exposure to PBDEs from e-waste and battery recycling has been found to be a common risk for workers. In southern China, workers have been observed to have high blood PBDE concentrations. E-waste surface dust can also be inhaled as fumes, or dermal contact. Dust particles can become suspended in air, contributing to air pollution, or leach into water and soils. Uncontrolled e-waste handling also poses a hazard to public health, another study has shown that vegetables near e-waste sites have been found to be contaminated with PBDEs.
Sulfation (sometimes spelled sulphation in British English) is the chemical reaction that entails the addition of SO3 group. In principle, many sulfations would involve reactions of sulfur trioxide (SO3). In practice, most sulfations are effected less directly. Regardless of the mechanism, the installation of a sulfate-like group on a substrate leads to substantial changes.
Sources: en.wikipedia.org
Once all the eggs are secured in the nest, the pair will spawn again. If more than one female is present in the breeding tank, the male may spawn with all of them. The spawning sessions will continue for two to four hours, and produce between 300 and 800 eggs. Dwarf gouramis have a fecundity of about 600 eggs.[1] Upon completion, the male will place a fine layer of bubbles beneath the eggs, assuring that they remain in the bubble nest. The male will protect the eggs and fry. In 12 to 24 hours the fry will hatch, and continue developing within the protection of the bubble nest. After three days they are sufficiently developed to be free swimming and leave the nest. When the fry are two to three days old the male should also be removed or he may consume the young. After spawning the female should be moved to a different tank. The male will now take sole responsibility for the eggs, aggressively defending the nest and surrounding territory. When first hatched, the tiny fry should be fed infusoria, and later, brine shrimp and finely ground flakes. Freeze-dried tablets may also be fed to older fry.
During the experiment, it was determined that the optimal blood-water dilution ratio is 1:2. The blood typing was executed by measuring the ratio of red blood cells (RBC) and plasma transport distances. The accuracy of the proposed PADs in blood typing was 92%, 85%, 89%, 93%, and 96% for A, B, AB, O, and Rh+ blood types respectively.
== Career == In December 1986, Cameron joined the Department of Chemical Engineering at the University of Wisconsin—Madison, as an assistant professor and advanced to full professor. The focus of his research was metabolic engineering (a field now more commonly known as synthetic biology) and industrial microbiology. One of his first projects was the engineering of the microbial pathway for 1,3-propanediol in Escherichia coli. This work was an early step in a process that was eventually commercialized by DuPont and Tate & Lyle. He is also the inventor of a process for the microbial production of 3-hydroxypropionic acid, which provides a bio-based route to industrial chemicals such as acrylic acid. In 1996 he did a sabbatical at the ETH Zurich (Switzerland) in the laboratory of James (Jay) E. Bailey. In 1998 he took a leave of absence to start the Biotechnology Development Center (BioTDC) at Cargill, Inc. in Minneapolis. In 2000 he officially left the University of Wisconsin. Cameron was at Cargill, Inc. from 1998 to 2006, where he was Director of Biotechnology and chief scientist. While at Cargill he worked closely with NatureWorks on the development of a low-pH process for lactic acid as a feedstock for polylactic acid. He and his team also worked with Cargill Ventures on deal-sourcing and due-diligence. In June 2006, Cameron moved from Cargill to join the newly formed Silicon Valley venture capital firm, Khosla Ventures, as chief scientific officer. In 2008, Cameron returned to the Midwest to help Piper Jaffray build and grow its clean tech investment business.
=== Lobbying the FDA === In 2011, the FDA made it a priority to clarify the requirements for approval for such a closed-loop monitoring and drug delivery device for T1D, and announced it was preparing draft guidelines. Breakthrough T1D launched a campaign to influence those guidelines to be lenient. After the first closed-loop device was approved in 2016, Breakthrough T1D lobbied insurance companies to cover it. The campaign also put resources into educating people with diabetes on how to navigate health insurance in the United States, and into lobbying Congress to continue funding diabetes research through the NIH. The FDA lobbying campaign was part of a gradual realignment of the organization to focus on issues other than helping find a cure for type 1 diabetes, but to help treat and manage the disease. This broadened scope meant that the organization increasingly directed its funds to education and advocacy, along with research funding. This included lobbying insurance companies to pay for CGM devices, educating patients on how to advocate for themselves, and lobbying Congress for more NIH funding.
In November 1965 the government of the British colony of Southern Rhodesia issued an illegal Unilateral Declaration of Independence. This government represented the country's small white minority and was led by Prime Minister Ian Smith. The black majority of the population had little influence on the government, which sought to continue white racial privileges. At the time of independence the Rhodesian Security Forces were relatively large and well trained and equipped. Two groups with armed elements emerged as the opposition to the white Rhodesian regime. These were the Zimbabwe African National Union (ZANU), whose military wing was the Zimbabwe African National Liberation Army (ZANLA), and the Zimbabwe African People's Union (ZAPU) and its armed wing the Zimbabwe People's Revolutionary Army (ZIPRA). Both groups were initially based in Zambia, and from the late 1960s began dispatching insurgents into Rhodesia who used guerrilla tactics. These attacks initially proved ineffective and the Rhodesian military, which had been bolstered by forces from South Africa, was able to effectively counter them. Rhodesia's security situation began to deteriorate from late 1972, when the guerrilla armies began making more effective attacks in the north-east of the country. The collapse of the Portuguese Empire in 1975 that led to the independence of Mozambique led to a further increase to the challenges facing the Rhodesian regime, with the guerrillas using that country as well as Botswana as bases.
Sources: en.wikipedia.org
Human-to-human transmission of SARS‑CoV‑2 was confirmed on 20 January 2020 during the COVID-19 pandemic. Transmission was initially assumed to occur primarily via respiratory droplets from coughs and sneezes within a range of about 1.8 metres (6 ft). Laser light scattering experiments suggest that speaking is an additional mode of transmission and a far-reaching one, indoors, with little air flow. Other studies have suggested that the virus may be airborne as well, with aerosols potentially being able to transmit the virus. During human-to-human transmission, between 200 and 800 infectious SARS‑CoV‑2 virions are thought to initiate a new infection. If confirmed, aerosol transmission has biosafety implications because a major concern associated with the risk of working with emerging viruses in the laboratory is the generation of aerosols from various laboratory activities which are not immediately recognisable and may affect other scientific personnel. Indirect contact via contaminated surfaces is another possible cause of infection. Preliminary research indicates that the virus may remain viable on plastic (polypropylene) and stainless steel (AISI 304) for up to three days, but it does not survive on cardboard for more than one day or on copper for more than four hours. The virus is inactivated by soap, which destabilises its lipid bilayer. Viral RNA has also been found in stool samples and semen from infected individuals.
Some individuals inherit DQ2.5 from one parent and an additional portion of the haplotype (either DQB1*02 or DQA1*05) from the other parent, increasing risk. Less commonly, some individuals inherit the DQA1*05 allele from one parent and the DQB1*02 from the other parent (DQ2.5trans), and these individuals are at similar risk of coeliac disease as those with a single DQ2.5-bearing chromosome 6. Among those with coeliac disease who do not have DQ2.5 (cis or trans) or DQ8 (encoded by the haplotype DQA1*03:DQB1*0302), 2-5% have the DQ2.2 isoform, and the remaining 2% lack DQ2 or DQ8. Other genetic factors have been reported in coeliac disease, but involvement in the disease has variable geographic recognition. Only the HLA-DQ loci show a consistent involvement across the global population. Many of the detected loci are associated with other autoimmune diseases. The prevalence of the HLA-DQ2 genotype and gluten consumption has increased over time. Since untreated coeliac disease can cause serious health problems and affect fertility, it would be expected that HLA-DQ2 and HLA-DQ8 would become less common. The opposite is true—they are most common in areas where gluten-rich foods have been eaten for thousands of years. The HLA-DQ2 gene may have been genetically favoured in the past because it helps protect against tooth decay.
Come to Dust is a post trip hop album by UK band Second Person. This is the third and final album from the band, and their first full-length studio release since their debut Chromatography. It was produced by Mark Maclaine (a.k.a. The Silence) at The Silence Corporation Studios, London. Some of the songs on the album were mixed by the Tony Platt.
∗Fifteen puffs were chosen to estimate the nicotine delivery of one traditional cigarette. Each e-cigarette cartridge, which varies across manufacturers, and each cartridge produces 10 to 250 puffs of vapor. This correlates to 5 to 30 traditional cigarettes. A puff usually lasts for 3 to 4 seconds. A 2014 study found there is wide differences in daily puffs in experienced vapers, which typically varies from 120 to 225 puffs per day. From puff-to-puff e-cigarettes do not provide as much nicotine as traditional cigarettes. A 2016 review found "The nicotine contained in the aerosol from 13 puffs of an e-cigarette in which the nicotine concentration of the liquid is 18 mg per milliliter has been estimated to be similar to the amount in the smoke of a typical tobacco cigarette, which contains approximately 0.5 mg of nicotine."
exon Any part of a gene that encodes a part of the final mature messenger RNA produced by that gene after introns have been removed by alternative splicing. The term refers to both the sequence as it exists within a DNA molecule and to the corresponding sequence in RNA transcripts.
Sources: en.wikipedia.org
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.
Single-receptor agents act predominantly at GLP-1R. Tirzepatide retains activity at GIPR, which is expressed in pancreatic islets, adipose tissue, and the central nervous system. The contribution of each receptor to the overall response is still an area of active study, and the relative weight of GIPR signaling in humans is not fully settled.
The fatty diacid moiety binds serum albumin, which reduces renal filtration of the active peptide. Additional resistance to enzymatic breakdown comes from non-natural residues in the backbone. Together these features produce an apparent half-life of about five days and permit weekly dosing intervals.
The peptide backbone and its fatty acid side chain are susceptible to degradation at elevated temperatures. Refrigeration slows hydrolysis, oxidation, and aggregation processes. Labeled storage ranges reflect stability data generated under defined conditions.